Khan Muhammad Saim, Malik Sidra, Basit Imran
Dr. Muhammad Saim Khan, MBBS, Armed Forces Institute of ophthalmology (AFIO), Rawalpindi, Pakistan.
Dr. Sidra Malik, MBBS, Armed Forces Institute of ophthalmology (AFIO), Rawalpindi, Pakistan.
Pak J Med Sci. 2016 Jan-Feb;32(1):130-3. doi: 10.12669/pjms.321.8169.
To determine mean change in visual acuity, corneal astigmatism and clinical appearance of pterygium after intralesional injection of 5-Fluorouracil.
This was a Quasi experimental study conducted at Armed Forces Institute of Ophthalmology, Rawalpindi, Pakistan from June 2014 to May 2015. Total 68 eyes of 54 patients were included in the study. Patients were treated by injecting 0.1 ml of 5-FU (5mg) weekly injections for 04 weeks. All the patients underwent ophthalmic clinical examination that included Uncorrected distant visual acuity (UCVA), corrected distant visual acuity (CDVA), keratometery with Auto Ref-keratometer (RK-F1, Canon) and slit lamp examination before and 04 weeks after the last injection.
Total 68 eyes of 54 patients (18 females and 36 males) were treated with intralesional injection of 5 FU. Out of total, 30 were right eyes while 38 were left eyes. Age of patients ranged from 23 to 53 years with mean age of 39.2 ± 4.90 years. Mean UCVA and corneal astigmatism before treatment were 0.162 ± 0.167 and 2.12 ± 1.53 respectively while the same parameters 04 weeks after last injection of 5 FU were 0.166 ± 0.168 and 1.92±1.45 respectively. The magnitude of induced change in astigmatism was (0.235 ± 1.35). Ninety seven percent of the patients showed improvement in clinical appearance.
Intralesional 5-FU injection results in significant clinical and cosmetic improvement of primary pterygium.
确定病灶内注射5-氟尿嘧啶后翼状胬肉的视力、角膜散光及临床表现的平均变化。
这是一项于2014年6月至2015年5月在巴基斯坦拉瓦尔品第武装部队眼科研究所进行的准实验性研究。该研究共纳入54例患者的68只眼。患者接受每周注射0.1 ml 5-FU(5mg),共注射4周的治疗。所有患者在最后一次注射前及注射后4周均接受眼科临床检查,包括未矫正远视力(UCVA)、矫正远视力(CDVA)、使用自动验光角膜曲率计(RK-F1,佳能)测量角膜曲率以及裂隙灯检查。
54例患者(18例女性和36例男性)的68只眼接受了病灶内注射5-FU治疗。其中,右眼30只,左眼38只。患者年龄在23至53岁之间,平均年龄为39.2±4.90岁。治疗前平均UCVA和角膜散光分别为0.162±0.167和2.12±1.53,而在最后一次注射5-FU后4周,相同参数分别为0.166±0.168和1.92±1.45。散光的诱导变化幅度为(0.235±1.35)。97%的患者临床表现有所改善。
病灶内注射5-FU可使原发性翼状胬肉在临床和外观上得到显著改善。